Close
ACHEMA MIDDLE EAST 2026

Synergising SaaS & Cloud Comm With AI For Better Pharma

The pharmaceutical backdrop is going through a remarkable shift pushed by disruptive technologies: Software as a Service- SaaS, Infrastructure as a Service- IaaS as...

Role of GenAI In Speeding Up Pharmaceuticals To Market

The fact is that Generative AI- GenAI is revolutionizing the life sciences sector, and one is just at the surface of it. It is worth...

The State of GenAI In The Pharmaceutical Industry Today

According to a recent survey from the Pistoia Alliance, AI and machine learning- ML are going to be the top technology investments when it...

Generic Drugs Safety Test Requests Pushed Back By The FDA

Apparently, when a grocery store goes on to steeply discount rotting cuts of meat or produce, would one buy them? May be not. If...

The Biopharma Spectrum May See Regulation Shifts In 2024

The scenario is that the regulators are all ramping up pressure when it comes to the biopharma industry in 2024. Pharma companies not only...

US, UK Look To Make Regulatory Changes In Life Sciences In 2024

Prominent regulatory changes throughout the numerous medical fields are coming in 2024, with pharma and medical device companies urged to be on with a...

7 Potential Drivers of The Life Sciences Landscape In 2024

The year 2023 was indeed quite a challenging year for the life sciences industry, which was marked by a chilly biotech financing environment, uncertainty...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...